Jan 29, 2018 21:51 pm UTC| Business
NEW YORK, Jan. 29, 2018 -- Wolf Haldenstein Adler Freeman Herz LLP announces that a federal securities class action lawsuit has been filed in the United States District Court for the Northern District of California...
Northwest Bancorporation, Inc. Reports Fourth Quarter and Year End 2017 Financial Results
Jan 29, 2018 21:47 pm UTC| Business
SPOKANE, Wash., Jan. 29, 2018 -- Northwest Bancorporation, Inc. (OTC:NBCT) (the “Company”), the holding company of Inland Northwest Bank (the “Bank” or “INB”), today reported financial results for the quarter and year...
American Leisure Holdings, Inc.'s GG Media Network Enters a Strategic Alliance with Thunder Gaming
Jan 29, 2018 21:46 pm UTC| Business
LOS ANGELES, Jan. 29, 2018 -- American Leisure Holdings, Inc. (OTC PINK:AMLH), parent of GG Media Network, an eSports production and content creation company, today announces it has entered into a strategic alliance...
Jan 29, 2018 21:46 pm UTC| Business
OKLAHOMA CITY, Jan. 29, 2018 -- Gulfport Energy Corporation (NASDAQ:GPOR) (“Gulfport” or the “Company”) today announced its 2018 capital budget, its 2018 operation outlook and that its board of directors has approved a...
QIWI Announces Extraordinary General Meeting of Shareholders
Jan 29, 2018 21:45 pm UTC| Business
NICOSIA, Cyprus, Jan. 29, 2018 -- QIWI plc (Nasdaq:QIWI), (MOEX:QIWI) ("QIWI" or the "Company") today announced that it will hold an extraordinary general meeting of shareholders (the "EGM") on Tuesday March 6, 2018, at...
Gulfport Energy Corporation Provides Fourth Quarter 2017 Operational Update
Jan 29, 2018 21:44 pm UTC| Business
OKLAHOMA CITY, Jan. 29, 2018 -- Gulfport Energy Corporation (NASDAQ:GPOR) (“Gulfport” or the “Company”) today provided an update for the quarter and year ended December 31, 2017. Key information includes the following: ...
CymaBay Announces Proposed Public Offering of Common Stock
Jan 29, 2018 21:44 pm UTC| Business
NEWARK, Calif., Jan. 29, 2018 -- CymaBay Therapeutics, Inc. (Nasdaq:CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, today...